Check my math, but $30 million at current price of $0.25 would yield 120 million shares. If that alone is enough to fund us through the end of the mCRC trial, that's a lot more palatable to me than the sale of the 500 million shares that the company asked us to authorize at the upcoming shareholder meeting. IMHO